Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Roberto Latini"'
Autor:
Giuseppe Vergaro, Yasuchika Takeishi, Ida Gustafsson, Inder S. Anand, Kai M. Eggers, Michael Egstrup, Aldo Clerico, Andrea Ripoli, Jay N. Cohn, Jennifer Meessen, Nick Marcks, Akiomi Yoshihisa, Claudio Passino, Hanna K. Gaggin, Alberto Aimo, Thor Ueland, Michele Emdin, Josep Lupón, Roberto Latini, James L. Januzzi, Antoni Bayes-Genis, Sandra Sanders-van Wijk, Ioannis Tentzeris, Rudolf A. de Boer, Jørgen Gravning, Kurt Huber, Hans-Peter Brunner-La Rocca
Publikováno v:
Clinical research in cardiology, 110(8), 1280-1291. Springer
Clinical Research in Cardiology, 110(8), 1280-1291. SPRINGER HEIDELBERG
Clinical Research in Cardiology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Clinical Research in Cardiology, 110(8), 1280-1291. SPRINGER HEIDELBERG
Clinical Research in Cardiology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background Higher body mass index (BMI) is associated with better outcome compared with normal weight in patients with HF and other chronic diseases. It remains uncertain whether the apparent protective role of obesity relates to the absence of comor
Autor:
Antonio Noto, Roberto Latini, Marco Magnoni, Felicita Andreotti, Christian Cadeddu Dessalvi, Daniele Andreini, Eleuterio Ferrannini, Aldo P. Maggioni, Attilio Maseri, Martino Deidda, Giuseppe Mercuro
Publikováno v:
International Journal of Cardiology. 336:14-21
Background Traditional cardiovascular risk factors (RFs) and coronary artery disease (CAD) do not always run parallel. We investigated functional-metabolic correlations of CAD, RFs, or neither in the CAPIRE (Coronary Atherosclerosis in Outlier Subjec
Autor:
Roberto Latini, Gian F Mureddu, Predictor Investigators, Luisa Ojeda-Fernandez, Lidia Staszewsky, Deborah Novelli, Peter Kastner, Serge Masson, Maurizio Mangiavacchi, Jennifer Meessen, Ursula-Henrike Wienhues-Thelen, Gianfranco Bazzoni, Giulia Cesaroni, Nera Agabiti, Alessandro Boccanelli
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders
BackgroundLittle is known about the clinical value of Insulin-like growth factor-binding protein-7 (IGFBP7), a cellular senescence marker, in an elderly general population with multiple co-morbidities and high prevalence of asymptomatic cardiovascula
Autor:
Pierpaolo Pellicori, Blerim Mujaj, Stephane Heymans, Fozia Z Ahmed, N. Girerd, Ping Wang, Arantxa González, Hans-Peter Brunner-La-Rocca, Javier Díez, Franco Cosmi, Frank T. Edelmann, Mark R. Hazebroek, João Pedro Ferreira, Joe Cuthbert, Andrew L. Clark, Johannes Petutschnigg, Mamas A. Mamas, Roberto Latini, Job A J Verdonschot, John G.F. Cleland, Beatrice Mariottoni, Patrick Rossignol, Javed Khan, Jan A. Staessen, Burkert Pieske, Faiez Zannad, Anne Pizard, Stéphanie Grojean, Timothy Collier, Philippe Rouet
Publikováno v:
JACC: Heart Failure
JACC: Heart Failure, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC: Heart Failure, Elsevier/American College of Cardiology, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC-Heart Failure, 9(4), 268-277. ELSEVIER SCI LTD
JACC: Heart Failure, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC: Heart Failure, Elsevier/American College of Cardiology, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC-Heart Failure, 9(4), 268-277. ELSEVIER SCI LTD
OBJECTIVES This study sought to further understand the mechanisms underlying effect of spironolactone and assessed its impact on multiple plasma protein biomarkers and their respective underlying biologic pathways.BACKGROUND In addition to their bene
Autor:
Edoardo Conte, Daniele Andreini, Marco Magnoni, Serge Masson, Saima Mushtaq, Sergio Berti, Mauro Canestrari, Giancarlo Casolo, Domenico Gabrielli, Roberto Latini, Paolo Marraccini, Tiziano Moccetti, Maria Grazia Modena, Gianluca Pontone, Marco Gorini, Aldo P. Maggioni, Attilio Maseri, A. Maseri, D. Andreini, S. Berti, M. Canestrari, G. Casolo, D. Gabrielli, R. Latini, M. Magnoni, P. Marraccini, S. Masson, T. Moccetti, M.G. Modena, G. Pontone, F. Gaspari, S. Ferrari, A. Cannata, N. Stucchi, M. Fois, R. Bernasconi, G. Balconi, T. Vago, T. Letizia, B. Bottazzi, R. Leone, I. Suliman, M. Sommaruga, P. Gremigni, R. Olivieri, L. Pennacchietti, M. Magnacca, M.G. Rossi, E. Pasotti, A. Clemente, S. Mushtaq, E. Mauro, R. Rossi, F. Pigazzani, L. Faggioni, M. Ciardetti, M. Puppato
Publikováno v:
Journal of Cardiovascular Computed Tomography. 15:73-80
Background High-risk coronary atherosclerosis features evaluated coronary CT angiography (CCTA) were suggested to have a prognostic role. The present study aimed to evaluate the association of circulating biomarkers with high-risk plaque features ass
Autor:
Salvatore Saccà, Gianpiero D'Amico, Marco Cerrito, Alessandro Cafaro, Sergio Ghiringhelli, Giuseppe Tarantini, Francesco Versaci, Matteo Tebaldi, F Sgura, Andrea Picchi, Roberto Latini, Francesco Giannini, Giulio G. Stefanini, Marco Ciardetti, Achille Gaspardone, Mauro Massussi, Federico De Marco, Alfonso Ielasi
Publikováno v:
The American Journal of Cardiology. 139:22-27
The coronary sinus (CS) Reducer is a novel device designed for the management of patients with severe angina symptoms refractory to optimal medical therapy and not amenable to further revascularization. Aim of this study was to investigate the effica
Autor:
Aldo P. Maggioni, Jennifer Meessen, Antonio Conti, Giovanni Targher, Deborah Novelli, Stefano Bonapace, Pier Luigi Temporelli, Alessandro Mantovani, Enrico Nicolis, Gianluigi Lunardi, Luigi Tavazzi, Roberto Latini
Publikováno v:
ESC Heart Failure, Vol 7, Iss 6, Pp 3288-3297 (2020)
ESC Heart Failure
ESC Heart Failure
Aims Ceramides exert several biological activities that may contribute to the pathophysiology of cardiovascular disease and heart failure (HF). The association between plasma levels of distinct ceramides (that have been previously associated with inc
Autor:
Kui Tong Gerard Leong, Robert N. Doughty, Fazlur Jaufeerally, Giuseppe Vergaro, Lars Gullestad, Jay N. Cohn, Antoni Bayes-Genis, Hans-Peter Brunner-La Rocca, Michele Emdin, Lieng H. Ling, Ida Gustafsson, Michael Egstrup, Kai M. Eggers, Yasuchika Takeishi, Hanna K. Gaggin, Hean Yee Ong, Richard W. Troughton, A. Mark Richards, Thor Ueland, Inder S. Anand, James L. Januzzi, Roberto Latini, Rudolf A. de Boer, Pål Aukrust, Claudio Passino, Carolyn S.P. Lam, Alberto Aimo, Josep Lupón, Tze P. Ng, Greg D. Gamble, Kurt Huber, Poh Shuah Daniel Yeo
Publikováno v:
European Journal of Heart Failure
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
European journal of heart failure, 22(11), 2078-2088. Wiley
European Journal of Heart Failure, 22(11), 2078-2088. Wiley
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
European journal of heart failure, 22(11), 2078-2088. Wiley
European Journal of Heart Failure, 22(11), 2078-2088. Wiley
This is the peer reviewed version of the following article: Aimo, A., Januzzi, J.L., Vergaro, G., Richards, A.M., Lam, C.S.P., Latini, R. ... Emdin, M. (2020). Circulating levels and prognostic value of soluble ST2 in heart failure are less influence
Autor:
Joseph J Cuthbert, Pierpaolo Pellicori, Johannes Petutschnigg, Franco Cosmi, Blerim Mujaj, João Pedro Ferreira, Fozia Z Ahmed, Nicolas Girerd, Faiez Zannad, Roberto Latini, Timothy Collier, Patrick Rossignol, Beatrice Mariottoni, Jan A. Staessen, John G.F. Cleland, Stephane Heymans, Andrew L. Clark, Job A J Verdonschot, Arantxa González, Hans-Peter Brunner-La Rocca
Publikováno v:
European journal of heart failure, 22(9), 1711-1723. Wiley
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2020, 22 (7), pp.1711-1723. ⟨10.1002/ejhf.1716⟩
European Journal of Heart Failure, 2020, 22 (7), pp.1711-1723. ⟨10.1002/ejhf.1716⟩
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2020, 22 (7), pp.1711-1723. ⟨10.1002/ejhf.1716⟩
European Journal of Heart Failure, 2020, 22 (7), pp.1711-1723. ⟨10.1002/ejhf.1716⟩
International audience; AIMS:Asymptomatic patients with coronary artery disease (CAD), hypertension and/or type 2 diabetes mellitus (T2DM) are at greater risk of developing heart failure (HF). Fibrosis, leading to myocardial and vascular dysfunction,
Publikováno v:
International Journal of Cardiology. 313:89-96
Background Variability of parameter measurements in heart failure with reduced ejection fraction (HFrEF) may contribute to reducing the prediction accuracy of available prognostic models. We investigated whether the use of longitudinal versus cross-s